SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008803
Filing Date
2024-05-31
Accepted
2024-05-31 08:00:25
Documents
17
Period of Report
2024-05-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20240530x8k.htm   iXBRL 8-K 84496
2 EX-3.1 sngx-20240530xex3d1.htm EX-3.1 22329
3 EX-99.1 sngx-20240530xex99d1.htm EX-99.1 22439
4 GRAPHIC sngx-20240530xex99d1001.jpg GRAPHIC 14345
  Complete submission text file 0001558370-24-008803.txt   298413

Data Files

Seq Description Document Type Size
5 EX-101.SCH sngx-20240530.xsd EX-101.SCH 4027
6 EX-101.DEF sngx-20240530_def.xml EX-101.DEF 3492
7 EX-101.LAB sngx-20240530_lab.xml EX-101.LAB 17908
8 EX-101.PRE sngx-20240530_pre.xml EX-101.PRE 10507
21 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20240530x8k_htm.xml XML 5030
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 241007739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)